Litfulo Capsule
Product Images NDC 63539-334

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Litfulo (NDC 63539-334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label Sample)

Litfulo (ritlecitinib) capsules 50 mg packaging label showing a 28-capsule pharmaceutical bottle label. The label features the Pfizer logo, directions to keep the capsules in the original package, storage instructions at 20-25°C with permitted excursions, and a caution not to crush or chew the capsules or eat the desiccant. Distributed by U.S. Pharmaceuticals, made in Ireland.*

FDA Label Image

Chemical Structure (Litfulo 01)

Chemical structure diagrams of ritlecitinib and an associated compound, likely shown as separate molecular entities. The image displays structural bonds and functional groups in line notation, representing the active ingredient ritlecitinib.*

FDA Label Image

Figure 1 (Litfulo 02)

A line graph comparing the proportion of subjects with SALT 20 response over 24 weeks for Litfulo 50 mg once daily versus placebo. The x-axis shows time in weeks, and the y-axis shows the proportion of subjects responding, with Litfulo showing a rising trend while placebo remains near constant.*

FDA Label Image

Logo (Litfulo 03)

FDA Label Image

Logo (Litfulo 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.